Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Income from Continuing Operations (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Income from Continuing Operations for 3 consecutive years, with 21265000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 79.59% to 21265000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 48958000.0 through Dec 2025, up 168.92% year-over-year, with the annual reading at 48958000.0 for FY2025, 168.92% up from the prior year.
  • Income from Continuing Operations hit 21265000.0 in Q4 2025 for Guardian Pharmacy Services, up from 9593000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 21265000.0 in Q4 2025 to a low of 105817000.0 in Q3 2024.
  • Historically, Income from Continuing Operations has averaged 1451100.0 across 3 years, with a median of 9433000.0 in 2025.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 1412.75% in 2024 and later surged 109.07% in 2025.
  • Year by year, Income from Continuing Operations stood at 14559000.0 in 2023, then dropped by 18.67% to 11841000.0 in 2024, then soared by 79.59% to 21265000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for GRDN at 21265000.0 in Q4 2025, 9593000.0 in Q3 2025, and 8827000.0 in Q2 2025.